Morgan Stanley analyst Courtney Yakavonis maintains Vulcan Materials (NYSE:VMC) with a Equal-Weight and lowers the price target from $203 to $199.
Barclays Maintains Overweight on Gossamer Bio, Raises Price Target to $18
Barclays analyst Carter Gould maintains Gossamer Bio (NASDAQ:GOSS) with a Overweight and raises the price target from $12 to $18.